<div id="readability-page-1">We recently published 10 Stocks Stealing Market Spotlight. Nuvation Bio Inc. (NYSE:NUVB) is one of the best performers on Wednesday. Nuvation rebounded by 12.05 percent on Wednesday to finish at $8.37 apiece following the stellar results of its phase 2 study for the efficacy of Safusidenib to treat of a type of brain tumor. In […]</div>

NUVB

<p>Nuvation Bio Inc.（纽约证券交易所代码：NUVB）的股票因 Safusidenib 的第二阶段临床试验结果积极而上涨 12.05%，至 8.37 美元。Safusidenib 是一种针对某种类型脑肿瘤的治疗药物</p>

Nuvation Bio (NUVB) 因临床试验结果表现出色而股价反弹 12%